Login / Signup

A cost-effectiveness analysis of pharmacotherapy versus prostatic urethral lift as initial therapy for patients with moderate benign prostatic hyperplasia.

Joshua Yi Min TungEdwin J AslimHenry Ss HoCynthia Chen
Published in: Expert review of pharmacoeconomics & outcomes research (2022)
Prostatic urethral lift is a cost-effective initial treatment option for men with moderate symptoms of benign prostatic hyperplasia.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • high intensity
  • urinary incontinence
  • prostate cancer
  • smoking cessation
  • depressive symptoms
  • physical activity
  • replacement therapy